Company Analysis
Sign in

MediWound Ltd. (MDWD)

Nasdaq: MDWD · Medicinal Chemicals & Botanical Products · Yavne, IL · filing with the SEC since 2013
Full chart Alerts Compare
Grade3.8
◀ Past 5.1● Present 2.7▶ Future 3.9
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2025, as filed
Revenue$17.0M-16.1%
Net income-$23.9M+21.0%
Earnings per share$-2.10+30.7%
Operating cash flow-$16.1M-18.3%
Cash$4.8M-47.6%
Debtn/a
Shareholders’ equity$43.6M+40.1%
Shares, diluted11.4M+14.2%
Return on equity-54.7%
The recordfrom its filings
Filings in 202643
Newest filingNov 12 · 4
Annual reportMar 5, 2026
Quarterly reportn/a
Next report due20-F by Apr 30
Insider sales, 12 months$100,000
Insider buys, 12 months$100,000
Patents granted7
Filer categoryAccelerated filer
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
16171819202122232425
As filed, in USD. Nothing here is a forecast.

News

Nov 12, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Nov 12, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Nov 12, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Nov 5, 2026 · SEC EDGAR · Form 424B5
Shelf offering
Open the filing on sec.gov
Nov 3, 2026 · SEC EDGAR · Form 424B5
Shelf offering
Open the filing on sec.gov
Sep 2, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton MDWD · research, not advice